BIA
RXST icon

Bell Investment Advisors’s RxSight RXST Stock Holding History

Bell Investment Advisors’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-9
Closed -$228 – 1958
2025
Q1 		$228 Hold
9
– – ﹤0.01% 1862
2024
Q4 		$310 Sell
9
-19
-68% -$857 ﹤0.01% 1856
2024
Q3 		$1.39K Buy
28
+19
+211% +$973 ﹤0.01% 1487
2024
Q2 		$542 Buy
+9
New +$514 ﹤0.01% 1788

Other funds holding RXST

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bell Investment Advisors's RXST Position: Q2 2025 in Review

Bell Investment Advisors sold out of RxSight (RXST) in Q2 2025, closing a stake of 9 shares — an estimated $228 sold.

Bell Investment Advisors first reported a position in RXST in Q2 2024 and held it in 4 quarters. The position peaked at $1.39K in Q3 2024. 174 funds tracked by Wall St. Rank hold RXST as of Q2 2025.

  • Bell Investment Advisors reported no remaining RxSight position as of Q2 2025 after selling out during the quarter.
  • Bell Investment Advisors sold 9 RxSight shares in Q2 2025, an estimated $228.
  • Bell Investment Advisors first reported a position in RxSight in Q2 2024 and held it in 4 quarters.
  • Bell Investment Advisors's RxSight position peaked at $1.39K in Q3 2024.
  • 174 funds tracked by Wall St. Rank held RxSight as of Q2 2025.

Based on Bell Investment Advisors's 13F filing for Q2 2025, filed 11 Aug 2025.